Literature DB >> 19814871

Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.

Yan-Ling Wu1, Li-Hua Lian, Ying-Zi Jiang, Ji-Xing Nan.   

Abstract

OBJECTIVES: The aim was to investigate the protective effect of salidroside isolated from Rhodiola sachalinensis A. Bor. (Crassulaceae) on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
METHODS: Hepatotoxicity was induced by an intraperitoneal injection of D-galactosamine (700 mg/kg) and lipopolysaccharide (10 mug/kg); salidroside (20, 50 and 100 mg/kg) was administered intraperitoneally 1 h before induction of hepatoxicity. Liver injury was assessed biochemically and histologically. KEY
FINDINGS: Salidroside attenuated the induced acute increase in serum aspartate aminotransferase and alanine aminotransferase activities, and levels of tumour necrosis factor-alpha levels and serum nitric oxide. It restored depleted hepatic glutathione, superoxide dismutase, catalase and glutathione peroxidase activities, decreased malondialdehyde levels and considerably reduced histopathological changes. Histopathological, immunohistochemical and Western blot analyses also demonstrated that salidroside could reduce the appearance of necrotic regions and expression of caspase-3 and hypoxia-inducible factor-1alpha in liver tissue.
CONCLUSIONS: Salidroside protected liver tissue from the oxidative stress elicited by D-galactosamine and lipopolysaccharide. The hepatoprotective mechanism of salidroside appear to be related to antioxidant activity and inhibition of hypoxia-inducible factor-1alpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19814871     DOI: 10.1211/jpp/61.10.0015

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  12 in total

1.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  Salidroside attenuates LPS-stimulated activation of THP-1 cell-derived macrophages through down-regulation of MAPK/NF-kB signaling pathways.

Authors:  Hong-Wu Wang; Ting Wu; Jun-Ying Qi; Ya-Qi Wang; Xiao-Ping Luo; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

3.  Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-κB and HMGB1 pathways through the upregulation of SIRT1.

Authors:  Kuo-Cheng Lan; Sung-Chuan Chao; Hsiao-Yi Wu; Chia-Lien Chiang; Ching-Chia Wang; Shing-Hwa Liu; Te-I Weng
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

4.  Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis.

Authors:  Bu-Gao Zhou; Hai-Mei Zhao; Xiu-Yun Lu; Xin Wang; Yong Zou; Rong Xu; Hai-Yang Yue; Yi Liu; Zheng-Yun Zuo; Duan-Yong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-30       Impact factor: 2.629

5.  Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice.

Authors:  Fenglin Li; Hong Tang; Furen Xiao; Jingli Gong; Yong Peng; Xiangle Meng
Journal:  Molecules       Date:  2011-12-01       Impact factor: 4.411

6.  Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways.

Authors:  Jiawen Wang; Yibin Pan; Yongqing Cao; Wei Zhou; Jingen Lu
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

7.  Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice.

Authors:  Ying Wang; Li-Na Gao; Yuan-Lu Cui; Heng-Li Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-17       Impact factor: 2.629

8.  Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.

Authors:  Ze-ran Yang; Hui-fang Wang; Tie-cheng Zuo; Li-li Guan; Ning Dai
Journal:  BMC Pharmacol Toxicol       Date:  2016-04-14       Impact factor: 2.483

Review 9.  Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases.

Authors:  Wei Zhuang; Lifeng Yue; Xiaofang Dang; Fei Chen; Yuewen Gong; Xiaolan Lin; Yumin Luo
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745

10.  Mixing ratio optimization for functional complex extracts of Rhodiola crenulata, Panax quinquefolius, and Astragalus membranaceus using mixture design and verification of immune functional efficacy in animal models.

Authors:  Hee-Do Hong; Jong-Chan Kim; Tae-Gyu Lim; Young-Ran Song; Chang-Won Cho; Mi Jang
Journal:  J Funct Foods       Date:  2017-11-28       Impact factor: 4.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.